Welcome, Guest |
TOPIC: AASLD: HCV Outcomes Under Scrutiny Treatment now 'predictably'
AASLD: HCV Outcomes Under Scrutiny Treatment now 'predictably' 4 years 11 months ago #22670
|
Genotype 1A ALT 473 AST 226 Virus Load 3,119,030 Results as of May-2016 5 week viral load/undetected as of 12/02/2016 Liver Biopsy Results from Feb 2013 Portal/Periportal chronic inflammation and mild interface hepatitis (Grade 2) Focal Lobular chronic inflammation (Grade 1) Portal/Periportal fibrosis (stage 1-2 trichrome and reticulin stains utilized) Negative Iron stains. |
AASLD: HCV Outcomes Under Scrutiny Treatment now 'predictably' 4 years 11 months ago #22675
| Great post Tommy, Too bad all these articles are by corrupt or ignorant people. The "real world" issue is most people are being denied treatment. Most people in the world have access to generic medications they can buy and import. I actually realized just today, that by accessing generics, that cost me $1400, I saved a lot of money. Had my insurance approved me for treatment, I would have paid at least $4500 co-pay. What a win   |
Gt 1a, F0, VL 6.5 million, AST 59, ALT 62 Started Twinvir 1/15/16 6 wk. labs VL UND, AST 27, ALT 20 EOT labs VL UND, AST 23, ALT 19 SVR 16, VL UND, AST 28, ALT 17 SVR 24 , VL UND, 10/8/16 SVR 125, VL UND, 9/22/18 SVR 230, VL UND, 10/3/20 |
AASLD: HCV Outcomes Under Scrutiny Treatment now 'predictably' 4 years 11 months ago #22678
|
YMMV |
